companydata.dkcompanydata.dk

TJ Biotech Holding ApS: Financial statements 2025

CVR: 41953616

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. That is a decrease of 40.4% compared with the year before. Equity in the 2025 report amounted to DKK 18,607,145. The solvency ratio was 77.8%.

Gross Profit
DKK 70,424
Profit/Loss
DKK 4,184,576
Equity
DKK 18,607,145
Total Assets
DKK 23,928,445
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-70K4.2M18.6M0
2024-118K668K14.4M0
2023-70K-9.5M13.8M0
2022-54K-216K23.3M0
2021-1.7M413K23.5M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is TJ Biotech Holding ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

TJ Biotech Holding ApS: The 2024 annual report is outJul 3, 2025

TJ Biotech Holding ApS has published its annual report for 2024. Gross profit came to DKK 118,224, and the net result was DKK 667,738.

About TJ Biotech Holding ApS

TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.

Source: annual report 2025, Danish Business Authority

Other financial years